HRSA’s HIV/AIDS Bureau recently announced two funding opportunity announcements (FOAs), supported with resources from the Secretary’s Minority AIDS Initiative Fund, that will support the development of comprehensive jurisdiction-level hepatitis C (HCV) screening, care, and treatment systems for HIV/HCV coinfected people of color.

Between 20-25% of people living with HIV in the United States are coinfected with HCV. HIV hastens the progression of HCV-related liver disease and liver disease is now one of the leading causes of death among people living with HIV in this country.

HAB’s new three-year program will support up to two Ryan White HIV/AIDS Program (RWHAP) Part A current grant recipients and up to two RWHAP Part B current grant recipients to increase jurisdiction-level capacity to provide comprehensive screening, care, and treatment for hepatitis C (HCV) among HIV/HCV coinfected RWHAP clients and thus, increase numbers of HIV/HCV coinfected people who are diagnosed, treated, and cured of HCV infection. The second FOA will support an Evaluation and Technical Assistance Center (ETAC) that will support the funded jurisdictions.

Details on both FOAs and related technical assistance (TA) webinars for prospective applicants is provided below:

HRSA-16-188

Jurisdictional Approach to Curing Hepatitis C among HIV/HCV Coinfected People of Color – Evaluation and Technical Assistance Center

http://www.grants.gov/web/grants/view-opportunity.html?oppId=283898

Pre-Application Technical Assistance Webinar for HRSA-16-188:

HRSA-16-189

Jurisdictional Approach to Curing Hepatitis C among HIV/HCV Coinfected People of Color – Jurisdictional Sites

http://www.grants.gov/web/grants/view-opportunity.html?oppId=283899

Pre-Application Technical Assistance Webinar for HRSA-16-189:

Corinna Dan, R.N., M.P.H., is Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health and Human ServicesThis post was originally published on AIDS.gov.